The Doctors Lounge - Hematology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog.
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
Study of leukemia survivors stresses value of long-term follow-up
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Survivors of acute lymphoblastic leukemia are increasingly likely to develop second tumors during adulthood.
Source: The Doctors Lounge - Hematology - June 18, 2007 Category: Hematology Tags: Hematology News Source Type: info
Test for p53 may help prescreen patients for proteosome inhibitors
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Test may help prescreen cancer patients to see if they are suitable candidates for proteasome inhibitors.
Source: The Doctors Lounge - Hematology - March 9, 2007 Category: Hematology Tags: Hematology News Source Type: info
Role for proteomics in identifying hematologic malignancies
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists have identified a set of biomarkers that could help clinicians identify myelodysplastic syndromes.
Source: The Doctors Lounge - Hematology - January 17, 2007 Category: Hematology Tags: Hematology News Source Type: info
Home care programme for bone marrow transplanted patients
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A clinical trial started five years ago allows patients undergoing BMT to avoid four weeks of hospitalisation.
Source: The Doctors Lounge - Hematology - October 23, 2006 Category: Hematology Tags: Hematology News Source Type: info
Canadian scientist invents alternative for IV immunoglobulin
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Costly IVIg may be replaced with synthetic product allowing better treatment for patients with life-threatening illness.
Source: The Doctors Lounge - Hematology - July 31, 2006 Category: Hematology Source Type: info
FDA approves extended dosing of Aranesp
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FDA has approved every-3-week dosing of Aranesp (darbepoetin alfa) for treatment of chemotherapy - induced anemia.
Source: The Doctors Lounge - Hematology - July 31, 2006 Category: Hematology Source Type: info
Aspirin may not provide optimum anti-coagulation for all patients
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Evidence is growing that some people will not respond to the anti-coagulant action of aspirin despite its regular intake.
Source: The Doctors Lounge - Hematology - July 31, 2006 Category: Hematology Source Type: info
New benchmark study of unrelated bone marrow transplantation for leukemia
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
Source: The Doctors Lounge - Hematology - July 31, 2006 Category: Hematology Source Type: info
Study finds new drug is potent treatment for CML
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AMN107, is about 20 times more potent than Gleevec and is effective in treating Gleevec-resistant disease.
Source: The Doctors Lounge - Hematology - July 31, 2006 Category: Hematology Source Type: info
Canadian scientist invents alternative for IV immunoglobulin
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Costly IVIg may be replaced with synthetic product allowing better treatment for patients with life-threatening illness.
Source: The Doctors Lounge - Hematology - May 31, 2006 Category: Hematology Source Type: info
FDA approves extended dosing of Aranesp
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FDA has approved every-3-week dosing of Aranesp (darbepoetin alfa) for treatment of chemotherapy - induced anemia.
Source: The Doctors Lounge - Hematology - May 20, 2006 Category: Hematology Source Type: info
Aspirin may not provide optimum anti-coagulation for all patients
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Evidence is growing that some people will not respond to the anti-coagulant action of aspirin despite its regular intake.
Source: The Doctors Lounge - Hematology - May 20, 2006 Category: Hematology Source Type: info
New benchmark study of unrelated bone marrow transplantation for leukemia
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
Source: The Doctors Lounge - Hematology - May 20, 2006 Category: Hematology Source Type: info
Study finds new drug is potent treatment for CML
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AMN107, is about 20 times more potent than Gleevec and is effective in treating Gleevec-resistant disease.
Source: The Doctors Lounge - Hematology - May 20, 2006 Category: Hematology Source Type: info
Cord blood transplantation now a viable option for adult leukemia
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers examined a new technique that combines two cord blood units from different donors for transplantation into leukemia patients.
Source: The Doctors Lounge - Hematology - May 20, 2006 Category: Hematology Source Type: info
